Found: 7
Select item for more details and to access through your institution.
New Approaches in Nanomedicine for Ischemic Stroke.
- Published in:
- Pharmaceutics, 2021, v. 13, n. 5, p. 757, doi. 10.3390/pharmaceutics13050757
- By:
- Publication type:
- Article
O2L-001, an innovative thrombolytic to evacuate intracerebral haematoma.
- Published in:
- Brain: A Journal of Neurology, 2023, v. 146, n. 11, p. 4690, doi. 10.1093/brain/awad237
- By:
- Publication type:
- Article
Optimized tPA: A non-neurotoxic fibrinolytic agent for the drainage of intracerebral hemorrhages.
- Published in:
- Journal of Cerebral Blood Flow & Metabolism, 2018, v. 38, n. 7, p. 1180, doi. 10.1177/0271678X17719180
- By:
- Publication type:
- Article
Toward safer thrombolytic agents in stroke: molecular requirements for NMDA receptor-mediated neurotoxicity.
- Published in:
- Journal of Cerebral Blood Flow & Metabolism, 2008, v. 28, n. 6, p. 1212, doi. 10.1038/jcbfm.2008.14
- By:
- Publication type:
- Article
Impacts of tissue-type plasminogen activator (tPA) on neuronal survival.
- Published in:
- Frontiers in Cellular Neuroscience, 2015, v. 9, p. 1, doi. 10.3389/fncel.2015.00415
- By:
- Publication type:
- Article
Retinal safety of intravitreal rtPA in healthy rats and under excitotoxic conditions.
- Published in:
- Molecular Vision, 2016, v. 22, p. 1
- By:
- Publication type:
- Article
Glutamate Controls tPA Recycling by Astrocytes, Which in Turn Influences Glutamatergic Signals.
- Published in:
- Journal of Neuroscience, 2012, v. 32, n. 15, p. 5186, doi. 10.1523/JNEUROSCI.5296-11.2012
- By:
- Publication type:
- Article